Nick Goldner, PhD

CEO & Co-Founder

Nick Goldner is a treatment resistance scientist, investor, and entrepreneur. He is dedicated to solving treatment resistance. He is the Co-Founder & CEO of resistanceBio, which focuses on developing therapies for treatment-resistant cancer. He received his Ph.D. from Washington University in St. Louis, where he focused on understanding and overcoming treatment resistance mechanisms to novel and approved compounds.

Email: Nick Goldner